Notification of Executive Chairman's Option Grant

8 August 2012

PuriCore plc

("PuriCore" or the "Company")

Notification of Executive Chairman's Option Grant

PuriCore(LSE: PURI), the water-based clean technology company, today announces that on 7 August 2012 the following options over Ordinary Shares in the Company were granted to Michael Ashton, Executive Chairman, under the terms of the PuriCore plc Executive Omnibus Incentive Plan. These options vest on the second and third anniversary of the date of grant subject to the achievement of performance conditions, are exercisable from the date of vesting until the seventh anniversary of the date of grant and carry an exercise price of 54 pence per share.

Enquiries:

About PuriCore

PuriCore plc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary solutions that protect people from the spread of infectious pathogens without causing harm to human health or the environment. The Company's products are used in a broad range of markets that depend upon effective pathogen control. PuriCore is the leading full provider of all products and services required for a safe, efficient, and compliant endoscope decontamination to protect patients in UK hospitals. The Company's products are the de facto standard for food safety in leading US supermarket chains. PuriCore also offers a breakthrough wound therapy solution to treat chronic and acute wounds including diabetic ulcers and burns.

PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK. To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.